Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (4)
  • Antibiotic
    (4)
  • TLR
    (4)
  • 5-HT Receptor
    (3)
  • Autophagy
    (2)
  • Amino Acids and Derivatives
    (1)
  • Anti-infection
    (1)
  • Bombesin Receptor
    (1)
  • Cholinesterase (ChE)
    (1)
  • Others
    (12)
TargetMol | Tags By Natures
  • Stevia
    (1)
TargetMol | Tags By ResearchField
  • Cancer
    (4)
  • Metabolism
    (4)
  • Infection
    (3)
  • Cardiovascular System
    (2)
  • Immune System
    (2)
  • Inflammation
    (2)
  • Nervous System
    (2)
  • Others
    (1)
Filter
Search Result
Results for "

enteric

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    27
    TargetMol | All_Pathways
  • Peptide Products
    2
    TargetMol | Peptide_Products
  • Natural Products
    3
    TargetMol | Natural_Products
  • Recombinant Protein
    2
    TargetMol | Recombinant_Protein
  • Cell Research
    7
    TargetMol | Cell_Research_Reagents
  • Reference Standards
    2
    TargetMol | Standard_Products
  • Sulfaguanidine
    Sulfaguine, Guanicil
    T051057-67-0
    Sulfaguanidine (Guanicil), a sulfonamide, is served as an anti-infective agent.
    • $35
    In Stock
    Size
    QTY
  • Nitazoxanide
    NSC 697855
    T154655981-09-4
    Nitazoxanide (NSC-697855) is a synthetic benzamide with antiprotozoal activity. Nitazoxanide exerts its antiprotozoal activity by interfering with the pyruvate ferredoxin/flavodoxin oxidoreductase dependent electron transfer reaction.
    • $38
    In Stock
    Size
    QTY
    TargetMol | Citations Cited
  • Hemicholinium 3
    Hemicholinium-3, Hemicholine
    T2227312-45-8
    Hemicholinium 3 is a potent and selective choline uptake blocker.
    • $41
    In Stock
    Size
    QTY
  • Lipopolysaccharides, from S. enterica serotype enteritidis
    LPS, from Salmonella enterica (Serotype enteritidis), Lipopolysaccharides (from S. enterica serotype enteritidis)
    TSW-00904
    Lipopolysaccharides, from S. enterica (Salmonella enterica) serotype enteritidis, are endotoxins derived from this serotype known for causing enteritis and serve as TLR-4 activators. This S-type LPS triggers the immune system's pathogen-associated molecular patterns (PAMP) and induces the secretion of exosomes. It consists of a typical tripartite structure: the O antigen, core oligosaccharide, and lipid A. These lipopolysaccharides can provoke a systemic inflammatory response, leading to increased plasma levels of TNF-α, IFN-γ, IL-6, IL-10, and nitrates.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Lipopolysaccharides, from S. enterica serotype minnesota
    LPS, from Salmonella enterica (Serotype minnesota), Lipopolysaccharides (from S. enterica serotype minnesota)
    TSW-00905
    Lipopolysaccharides (LPS) are specific endotoxins that serve as a major component of the cell walls in gram-negative bacteria. Composed of Lipid A, a core oligosaccharide, and an O-specific polysaccharide, LPS strongly stimulates the immune system by binding to Toll-like receptor 4 (TLR4) on immune cells, triggering inflammatory responses. In most Salmonella serotypes, the LPS features a complex O-antigen (OAg) structure, with core oligosaccharide OAg units ranging from 16 to over 100 repeats. Mutations in OAg regulatory factors can alter the OAg structure, affecting Salmonella interactions with epithelial cells. Strains with long OAgs show increased translocation and invasion by SPI1-T3SS effector proteins, while strains lacking OAg entirely exhibit increased invasiveness and adhesion. This product is derived from Salmonella enterica serotype minnesota and is utilized for studies on host immune activation and its roles in inflammation and immune modulation.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Lipopolysaccharides, from S. enterica serotype typhimurium
    LPS, from Salmonella enterica (Serotype typhimurium), Lipopolysaccharides (from S. enterica serotype typhimurium)
    TSW-00906
    Lipopolysaccharides, from S. enterica (Salmonella enterica) serotype typhimurium, are endotoxins and TLR4 activators derived from the serotype of this bacterium, classified as S-type LPS. They display a characteristic three-part structure: O antigen, core oligosaccharide, and lipid A. These lipopolysaccharides influence bacterial fate within dendritic cells (DC), determining the uptake, degradation, and activation of immune functions in DC cells.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Lipopolysaccharides, from S. enterica serotype abortus equi
    LPS, from Salmonella enterica (Serotype abortus equi), Lipopolysaccharides (from S. enterica serotype abortus equi)
    TSW-00907
    Lipopolysaccharides from *Salmonella enterica* serotype Abortusequi are endotoxins and TLR-4 activators derived from intestinal S. enterica. They are mutated R-type LPSs that serve as pathogen-associated molecular patterns (PAMP) to activate the immune system and induce cell secretion of exosomes. These lipopolysaccharides consist of a core oligosaccharide and lipid A. *S. enterica* serotype Abortusequi is a key pathogen causing abortion in mares and is associated with neonatal septicemia, multiple abscesses, orchitis, and polyarthritis in equine species. Grouping is primarily based on lipopolysaccharide (O-antigen) and flagellin protein (H-antigen).
    • Inquiry Price
    Inquiry
    Size
    QTY
  • Eprosartan
    Teveten, KF-108566J free base
    T2531L133040-01-4
    Eprosartan (SKF-108566J free base) is a selective, competitive nonpeptide angiotensin II receptor antagonist with high affinity for AT1 receptor subtypes, used as an antihypertensive agent. It exhibits inhibitory effects on angiotensin II receptors with IC50 values of 9.2 nM in rat adrenocortical membranes and 3.9 nM in human adrenocortical membranes.
    • $39
    In Stock
    Size
    QTY
  • BAY 73-1449
    BAY73-1449, BAY-73-1449
    T26745693790-96-4
    BAY 73-1449 is a potent and selective antagonist of the prostacyclin receptor (IC50 < 0.1 nM).
    • $37
    In Stock
    Size
    QTY
  • D-3263 hydrochloride
    EC D-3263 HCl, D3263 HCl salt
    T10929L1008763-54-9In house
    D-3263 hydrochloride (D3263 HCl salt) is enteric-coated, orally bioavailable transient receptor potential melatonin member 8 (TRPM8) agonist.
    • $43
    In Stock
    Size
    QTY
  • Florfenicol
    SCH-25298, (-)-Florfenicol
    T0454L73231-34-2
    Florfenicol (SCH-25298), a fluorinated synthetic analog of thiamphenicol, is currently indicated for the therapy of bovine respiratory disease (BRD) associated with Mannheimia (Pasteurella) haemolytica, Haemophilus somnus, and Pasteurella multocida, for therapy of bovine interdigital phlegmon (foot rot, infectious pododermatitis, acute interdigital necrobacillosis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus. This compound is also used in aquaculture and is approved for use in the United States for the therapy of enteric septicemia in catfish.
    • $47
    In Stock
    Size
    QTY
  • Rebaudioside D
    T2S184063279-13-0
    Rebaudioside D is a potential sweetener. Rebaudioside D shows similar stability when exposed to simulate stomach and small intestine fluids, with susceptibility to hydrolytic degradation by enteric bacteria collected from the cecum.
    • $30
    In Stock
    Size
    QTY
  • SulfadiMethoxine sodium
    T81331037-50-9
    Sulfadimethoxine is a antimicrobial agent, treatment of respiratory, urinary tract, enteric, and soft tissue infections
    • $35
    In Stock
    Size
    QTY
  • Gastrin-Releasing Peptide, human(TFA)
    TP1325L
    Gastrin-Releasing Peptide, human(TFA) is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function. The post-ganglionic fibers of the vagus nerve that innervate the G cells of the stomach release GRP, which stimulates the G cells to release gastrin.
    • $56
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • RS 23579-190
    RS23579-190
    T212777172679-58-2
    RS 23579-190 is a highly selective 5-HT receptor antagonist in neuropharmacology. Capable of specifically blocking serotonin-mediated downstream excitatory postsynaptic potentials at picomolar concentrations, it is frequently used to dissect serotonergic signaling pathways within the gastrointestinal enteric nervous system and central cognitive networks.
    • $195
    In Stock
    Size
    QTY
  • Alosetron hydrochloride
    Lotronex, GR 68755X, GR 68755C, GR 68755
    T2525122852-69-1
    Alosetron hydrochloride (GR 68755) is the hydrochloride salt form of alosetron, a potent and selective 5-HT3 receptor antagonist. Alosetron blocks the actions of serotonin at 5-HT3 sites in the peripheral nervous system, particularly on enteric and nociceptive sensory neurons, thereby affecting the regulation of visceral pain, decreasing gastrointestinal contraction and motility, and decreasing gastrointestinal secretions.
    • $31
    In Stock
    Size
    QTY
  • CRS-3123
    REP-3123, REP 3123, CRS 3123
    T270881013915-71-3
    CRS-3123, a methionyl-tRNA synthetase inhibitor, is used potentially for the treatment of enteric infections.
    • Inquiry Price
    3-6 months
    Size
    QTY
  • Allolactose
    T2988228447-39-4
    Allolactose is a disaccharide used as an inducer of the lac operon in Escherichia coli and many other enteric bacteria.
    • Inquiry Price
    3-6 months
    Size
    QTY
  • RET-IN-9
    T631832649418-11-9
    RET-IN-9 is a potent inhibitor of RET, a single-channel transmembrane receptor tyrosine kinase involved in kidney and enteric nervous system development, as well as in maintaining homeostasis in the nervous, endocrine, hematopoietic, and male reproductive systems. RET-IN-9 is potentially useful in studying RET-related diseases, including non-small cell lung cancer and medullary thyroid cancer.
    • $1,520
    10-14 weeks
    Size
    QTY
  • L-Aspartic acid sodium
    Disodium L-aspartate
    T652705598-53-8
    L-Aspartic acid sodium is the sodium salt form of the non-essential amino acid L-Aspartic acid that is employed to prepare polymeric carriers (e.g., poly(L-aspartic acid)) for prodrugs targeting colon and cecal tissues. Additionally, it is a key tool for investigating metabolic alterations in inflammatory conditions and studying its role as a metabolic hub hijacked by viruses, such as the enteric coronavirus PDCoV.
      Inquiry
    • Mosapride citrate dihydrate
      TAK-370, Mosapride Citrate, GR-107719-B, GR 107719 B, AS-4370, AS 4370
      T6597L636582-62-2
      Mosapride Citrate is a 5-HT4 receptor agonist used to stimulate gastrointestinal motility via acetylcholine. Mosapride Citrate facilitates acetylcholine release from the enteric cholinergic neurons.
      • $98
      Inquiry
      Size
      QTY
    • Florfenicol (Standard)
      TMSM-119173231-34-2
      Florfenicol (Standard) is the standard substance of Florfenicol, and it is applicable for quantitative analysis, quality control, and related research in biochemical experiments. Florfenicol (SCH-25298), a fluorinated synthetic analog of thiamphenicol, is currently indicated for the therapy of bovine respiratory disease (BRD) associated with Mannheimia (Pasteurella) haemolytica, Haemophilus somnus, and Pasteurella multocida, for therapy of bovine interdigital phlegmon (foot rot, infectious pododermatitis, acute interdigital necrobacillosis) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus. This compound is also used in aquaculture and is approved for use in the United States for the therapy of enteric septicemia in catfish.
      • $36
      7-10 days
      Size
      QTY
    • Rebaudioside D (Standard)
      TMSM-272063279-13-0
      Rebaudioside D (Standard) is a reference standard for research and analysis in studies involving Rebaudioside D. Rebaudioside D is a potential sweetener. Rebaudioside D shows similar stability when exposed to simulate stomach and small intestine fluids, with susceptibility to hydrolytic degradation by enteric bacteria collected from the cecum.
      • $557
      7-10 days
      Size
      QTY
    • Gastrin-Releasing Peptide, human
      TP132593755-85-2
      Gastrin-Releasing Peptide, human is a regulatory human peptide that elicits gastrin release and regulates gastric acid secretion and enteric motor function. The post-ganglionic fibers of the vagus nerve that innervate the G cells of the stomach release GRP, which stimulates the G cells to release gastrin.
      • $1,330
      35 days
      Size
      QTY